⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of EUROAPI and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
EUROAPI
↗Paris, France
EUROAPI is a global leader in the development, manufacturing, and distribution of active pharmaceutical ingredients (APIs) and intermediates for human and veterinary use. Spun off from Sanofi in 2021, the company operates a significant industrial network across Europe, offering a portfolio of approximately 200 APIs and specialized Contract Development and Manufacturing Organization (CDMO) services.
The company leverages advanced technologies including microbial fermentation, peptide synthesis, particle engineering, and complex small molecule synthesis. EUROAPI serves a diverse client base ranging from major pharmaceutical companies to biotech firms, focusing on securing the healthcare value chain through high-quality, sustainable, and reliable API solutions.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$500M-$1B
Founded:2020
Ownership:public
Status:operating
FUNDING
Total Raised:$825M
Investors:Sanofi (former parent)
STOCK
Exchange:Euronext Paris
Ticker:EAPI
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (API/CDMO Provider)
Modalities:Small molecule, Peptides, Oligonucleotides, Steroids, Hormones, Prostaglandins
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:BianoGMP
Key Partnerships:Abolis Biotechnologies (microbial strain development), Priothera (CDMO agreement), Sanofi (major client/partner)
COMPETITION
Position:Leader
Competitors:Divis Laboratories, Lonza, Catalent, Thermo Fisher Scientific (Patheon)
LEADERSHIP
Key Executives:
Emmanuel L.R. Blin - Independent Chairman
Board Members:Elizabeth Ann Bastoni, Cecile Dussart, Tristan Imbert, Mattias Perjos
LINKS
Website:euroapi.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with EUROAPI. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.